Literature DB >> 15243059

Studies on the involvement of the exopolysaccharide produced by cystic fibrosis-associated isolates of the Burkholderia cepacia complex in biofilm formation and in persistence of respiratory infections.

Mónica V Cunha1, Sílvia A Sousa, Jorge H Leitão, Leonilde M Moreira, Paula A Videira, Isabel Sá-Correia.   

Abstract

Bacteria belonging to the Burkholderia cepacia complex (BCC) are important opportunistic pathogens that lead to respiratory infections in patients with cystic fibrosis (CF). The clinical outcome following colonization with BCC bacteria is highly variable, and so far, unpredictable. A large percentage (80 to 90%) of BCC isolates from CF patients produce the exopolysaccharide (EPS) cepacian, which has been hypothesized to play a role in the colonization and persistence of these bacteria in the CF lung. In this work, we demonstrate that although it is not required for the initiation of biofilm formation, cepacian plays a role in the establishment of thick biofilms. This conclusion was based on a comparison of the abilities of EPS-defective mutants derived from a B. cepacia mucoid CF isolate by random plasposon insertion mutagenesis and the ability of the parental strain to form biofilms. However, the systematic characterization of 108 CF isolates, corresponding to 15 distinct strains, indicated that other strain-dependent factors are also involved in the development of thick, mature biofilms. The isolates examined belonged to the species B. cepacia, B. multivorans, B. cenocepacia, and B. stabilis and were obtained during a 7-year period of surveillance from 21 CF patients receiving care at the major Portuguese CF center. Most of them (90%) were serial isolates from 12 persistently infected patients. In spite of the concept that bacteria growing in biofilms display more resistance to antibiotics and to host phagocyte killing than do planktonically growing cells, no clear correlation could be established between the ability of the various strains examined to produce EPS and/or to form biofilms in vitro and the persistence or virulence of the respiratory infections they caused in different patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15243059      PMCID: PMC446245          DOI: 10.1128/JCM.42.7.3052-3058.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  38 in total

1.  Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis.

Authors:  J R Govan; P H Brown; J Maddison; C J Doherty; J W Nelson; M Dodd; A P Greening; A K Webb
Journal:  Lancet       Date:  1993-07-03       Impact factor: 79.321

2.  Structural elucidation of a novel exopolysaccharide produced by a mucoid clinical isolate of Burkholderia cepacia. Characterization of a trisubstituted glucuronic acid residue in a heptasaccharide repeating unit.

Authors:  S Cérantola; A Lemassu-Jacquier; H Montrozier
Journal:  Eur J Biochem       Date:  1999-03

3.  Vibrio cholerae O1 El Tor: identification of a gene cluster required for the rugose colony type, exopolysaccharide production, chlorine resistance, and biofilm formation.

Authors:  F H Yildiz; G K Schoolnik
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

4.  An epidemic of burkholderia cepacia transmitted between patients with and without cystic fibrosis.

Authors:  A Holmes; R Nolan; R Taylor; R Finley; M Riley; R Z Jiang; S Steinbach; R Goldstein
Journal:  J Infect Dis       Date:  1999-05       Impact factor: 5.226

Review 5.  Burkholderia cepacia: medical, taxonomic and ecological issues.

Authors:  J R Govan; J E Hughes; P Vandamme
Journal:  J Med Microbiol       Date:  1996-12       Impact factor: 2.472

6.  Marked phenotypic variability in Pseudomonas cepacia isolated from a patient with cystic fibrosis.

Authors:  G Y Larsen; T L Stull; J L Burns
Journal:  J Clin Microbiol       Date:  1993-04       Impact factor: 5.948

Review 7.  Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia.

Authors:  J R Govan; V Deretic
Journal:  Microbiol Rev       Date:  1996-09

8.  Polysaccharide production in Pseudomonas cepacia.

Authors:  D G Allison; M J Goldsbrough
Journal:  J Basic Microbiol       Date:  1994       Impact factor: 2.281

9.  Production of mucoid exopolysaccharide during development of Pseudomonas aeruginosa biofilms.

Authors:  B D Hoyle; L J Williams; J W Costerton
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

10.  Initiation of biofilm formation in Pseudomonas fluorescens WCS365 proceeds via multiple, convergent signalling pathways: a genetic analysis.

Authors:  G A O'Toole; R Kolter
Journal:  Mol Microbiol       Date:  1998-05       Impact factor: 3.501

View more
  52 in total

Review 1.  A decade of Burkholderia cenocepacia virulence determinant research.

Authors:  Slade A Loutet; Miguel A Valvano
Journal:  Infect Immun       Date:  2010-07-19       Impact factor: 3.441

2.  Functional analysis of Burkholderia cepacia genes bceD and bceF, encoding a phosphotyrosine phosphatase and a tyrosine autokinase, respectively: role in exopolysaccharide biosynthesis and biofilm formation.

Authors:  Ana S Ferreira; Jorge H Leitão; Sílvia A Sousa; Ana M Cosme; Isabel Sá-Correia; Leonilde M Moreira
Journal:  Appl Environ Microbiol       Date:  2006-11-17       Impact factor: 4.792

3.  Differential mucoid exopolysaccharide production by members of the Burkholderia cepacia complex.

Authors:  James E A Zlosnik; Trevor J Hird; Monica C Fraenkel; Leonilde M Moreira; Deborah A Henry; David P Speert
Journal:  J Clin Microbiol       Date:  2008-02-06       Impact factor: 5.948

4.  SNaPBceBcon: a Practical Tool for Identification and Genotyping of Burkholderia cepacia and Burkholderia contaminans.

Authors:  Ricardo Araujo; Rita Caramalho; Carla Coutinho; Isabel Sá-Correia
Journal:  J Clin Microbiol       Date:  2015-12-09       Impact factor: 5.948

5.  Cloning, expression, purification, crystallization and preliminary crystallographic studies of BceC, a UDP-glucose dehydrogenase from Burkholderia cepacia IST408.

Authors:  Joana Rocha; Alma O Popescu; Isabel Sá-Correia; Arsénio M Fialho; Carlos Frazão
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2010-02-24

6.  Regulator LdhR and d-Lactate Dehydrogenase LdhA of Burkholderia multivorans Play Roles in Carbon Overflow and in Planktonic Cellular Aggregate Formation.

Authors:  Inês N Silva; Marcelo J Ramires; Lisa A Azevedo; Ana R Guerreiro; Andreia C Tavares; Jörg D Becker; Leonilde M Moreira
Journal:  Appl Environ Microbiol       Date:  2017-09-15       Impact factor: 4.792

7.  σ54-Dependent Response to Nitrogen Limitation and Virulence in Burkholderia cenocepacia Strain H111.

Authors:  Martina Lardi; Claudio Aguilar; Alessandro Pedrioli; Ulrich Omasits; Angela Suppiger; Gerardo Cárcamo-Oyarce; Nadine Schmid; Christian H Ahrens; Leo Eberl; Gabriella Pessi
Journal:  Appl Environ Microbiol       Date:  2015-04-03       Impact factor: 4.792

8.  Comparative transcriptomic analysis of the Burkholderia cepacia tyrosine kinase bceF mutant reveals a role in tolerance to stress, biofilm formation, and virulence.

Authors:  Ana S Ferreira; Inês N Silva; Vítor H Oliveira; Jörg D Becker; Michael Givskov; Robert P Ryan; Fábio Fernandes; Leonilde M Moreira
Journal:  Appl Environ Microbiol       Date:  2013-02-22       Impact factor: 4.792

9.  Identification of Burkholderia cenocepacia strain H111 virulence factors using nonmammalian infection hosts.

Authors:  Stephan Schwager; Kirsty Agnoli; Manuela Köthe; Friederike Feldmann; Michael Givskov; Aurelien Carlier; Leo Eberl
Journal:  Infect Immun       Date:  2012-10-22       Impact factor: 3.441

Review 10.  Nanoparticle-Based Therapies for Wound Biofilm Infection: Opportunities and Challenges.

Authors:  Min-Ho Kim
Journal:  IEEE Trans Nanobioscience       Date:  2016-03-02       Impact factor: 2.935

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.